Sweegen and its commercialization partner, Conagen, announced the successful scale-up of two types of sweet proteins, thaumatin I and thaumatin II. The scale-up was done using the same peptide production...
Contact us to learn the benefits of becoming a Lux member.
Or call us now
For North America (Boston Headquarters)
+1 (617) 502-5300
For EMEA (Amsterdam)
+31 20 280 7900
For APAC (Singapore)
+65 6592-6978